Greg Lucier, Brent Jacobs, Duncan Whitney, Andrew von Eschenbach, Lester Crawford, Douglas Throckmorton, GE Healthcare, Ambion, ABI, MDS Sciex, Sigma-Aldrich, PerkinElmer, NCI | GenomeWeb


Greg Lucier, president and CEO of Invitrogen, has been elected to the board of trustees of The Burnham Institute for Medical Research. Also elected to the board was Brent Jacobs, founder of Biocom, a life sciences industry association representing companies in San Diego and Southern California.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.